Weight gain among treatment‐naïve persons with HIV starting integrase inhibitors compared to non‐nucleoside reverse transcriptase inhibitors or protease inhibitors in a large observational cohort in the United States and Canada

Treatment Naïve ◽

Observational Cohort

Pregnancy and neonatal outcomes in women with HIV-1 exposed to integrase inhibitors, protease inhibitors and non-nucleoside reverse transcriptase inhibitors: an observational study

Infection ◽

10.1007/s15010-019-01384-5 ◽

2020 ◽

Vol 48 (2) ◽

pp. 249-258

Author(s):

Marco Floridia ◽

◽

Serena Dalzero ◽

Vania Giacomet ◽

Enrica Tamburrini ◽

...

Keyword(s):

Observational Study ◽

Reverse Transcriptase ◽

Protease Inhibitors ◽

Neonatal Outcomes ◽

Integrase Inhibitors ◽

Women With Hiv ◽

Hiv 1

Ultra-performance liquid chromatographic method for simultaneous quantification of HIV non-nucleoside reverse transcriptase inhibitors and protease inhibitors in human plasma

Journal of the Brazilian Chemical Society ◽

10.1590/s0103-50532011000100018 ◽

2011 ◽

Vol 22 (1) ◽

pp. 134-141 ◽

Cited By ~ 7

Author(s):

Marina V. Antunes ◽

Júlia Poeta ◽

Jorge P. Ribeiro ◽

Eduardo Sprinz ◽

Rafael Linden

Keyword(s):

Reverse Transcriptase ◽

Human Plasma ◽

Protease Inhibitors ◽

Chromatographic Method ◽

Simultaneous Quantification ◽

Liquid Chromatographic Method ◽

Liquid Chromatographic

Protease inhibitors/nucleoside reverse transcriptase inhibitors

Reactions Weekly ◽

10.1007/s40278-020-73423-6 ◽

2020 ◽

Vol 1785 (1) ◽

pp. 442-442

Keyword(s):

Reverse Transcriptase ◽

Protease Inhibitors ◽

A comparison of three highly active antiretroviral treatment strategies consisting of non-nucleoside reverse transcriptase inhibitors, protease inhibitors, or both in the presence of nucleoside reverse transcriptase inhibitors as initial therapy (CPCRA 058 FIRST Study): a long-term randomised trial

The Lancet ◽

10.1016/s0140-6736(06)69861-9 ◽

2006 ◽

Vol 368 (9553) ◽

pp. 2125-2135 ◽

Cited By ~ 100

Author(s):

Rodger D MacArthur ◽

Richard M Novak ◽

Grace Peng ◽

Li Chen ◽

Ying Xiang ◽

...

Keyword(s):

Reverse Transcriptase ◽

Protease Inhibitors ◽

Antiretroviral Treatment ◽

Randomised Trial ◽

Treatment Strategies ◽

Initial Therapy ◽

Highly Active

Viro-immunological efficacy and tolerability of dolutegravir-based regimens compared to regimens based on other integrase strand inhibitors, protease inhibitors or non-nucleoside reverse transcriptase inhibitors in patients with acute HIV-1 infection: A multicenter retrospective cohort study

International Journal of Antimicrobial Agents ◽

10.1016/j.ijantimicag.2019.06.003 ◽

2019 ◽

Vol 54 (4) ◽

pp. 487-490 ◽

Cited By ~ 3

Author(s):

F. Lagi ◽

G. Baldin ◽

M. Colafigli ◽

A. Capetti ◽

G. Madeddu ◽

...

Keyword(s):

Cohort Study ◽

Reverse Transcriptase ◽

Protease Inhibitors ◽

Retrospective Cohort Study ◽

Retrospective Cohort ◽

Acute Hiv ◽

Hiv 1

Non-nucleoside reverse transcriptase inhibitors emerging as an attractive alternative to protease inhibitors in HIV combination therapy regimens

Drugs & Therapy Perspectives ◽

10.2165/00042310-200117190-00002 ◽

2001 ◽

Vol 17 (19) ◽

pp. 4-7

Author(s):

&NA;

Keyword(s):

Combination Therapy ◽

Reverse Transcriptase ◽

Protease Inhibitors ◽

Attractive Alternative ◽

Concentrations of protease inhibitors (PIs) and non-nucleoside reverse transcriptase inhibitors (NNRTIs) in the female genital tract may vary between different drugs,

Inpharma Weekly ◽

10.2165/00128413-200514750-00047 ◽

2005 ◽

Vol &NA; (1475) ◽

pp. 19

Author(s):

&NA;

Keyword(s):

Reverse Transcriptase ◽

Protease Inhibitors ◽

Genital Tract ◽

Female Genital Tract ◽

Female Genital

High-performance liquid chromatography assay for the quantification of HIV protease inhibitors and non-nucleoside reverse transcriptase inhibitors in human plasma

Journal of Chromatography B ◽

10.1016/j.jchromb.2004.03.002 ◽

2004 ◽

Vol 805 (2) ◽

pp. 241-247 ◽

Cited By ~ 48

Author(s):

Naser L Rezk ◽

Richard R Tidwell ◽

Angela D.M Kashuba

Keyword(s):

High Performance Liquid Chromatography ◽

Liquid Chromatography ◽

Reverse Transcriptase ◽

Human Plasma ◽

Protease Inhibitors ◽

High Performance ◽

Hiv Protease ◽

Hiv Protease Inhibitors ◽

Why switch from protease inhibitors (PI) to non-nucleoside reverse transcriptase inhibitors (NNRTI)?

HIV Medicine ◽

10.1046/j.1468-1293.2000.00006.x ◽

2000 ◽

Vol 1 (Supplement 1) ◽

pp. 7-10 ◽

Cited By ~ 4

Author(s):

Al Pozniak

Keyword(s):

Reverse Transcriptase ◽

Protease Inhibitors ◽

Effectiveness of switching from protease inhibitors to dolutegravir in combination with nucleoside reverse transcriptase inhibitors as maintenance antiretroviral therapy among HIV-positive patients

International Journal of Antimicrobial Agents ◽

10.1016/j.ijantimicag.2019.03.016 ◽

2019 ◽

Vol 54 (1) ◽

pp. 35-42 ◽

Cited By ~ 10

Author(s):

Guan-Jhou Chen ◽

Hsin-Yun Sun ◽

Sui-Yuan Chang ◽

Aristine Cheng ◽

Yu-Shan Huang ◽

...

Keyword(s):

Antiretroviral Therapy ◽

Reverse Transcriptase ◽

Protease Inhibitors ◽

Hiv Positive ◽